
Island Pharmaceuticals Employs FDA Animal Rule in Development of Galidesivir to Counter Deadly Marburg Virus

Zuleika Gold and Catalyst Metals Settle Five-Year Dispute over Plutonic Gold Mine

Calix Signs $35m Development Agreement with Rio Tinto for Zesty Green Iron Demonstration Plant
Market Overview
ASX 200 Index
| Code | Company | Price | Change | % |
|---|

Banking Competition Ramping Up As Big Four Falter
It may have escaped your notice, but there is a quiet war going on in Australia’s banking system, growing signs that the old order is slowly passing away and competition is hotting up.

Wrap: Four months of gains wiped out in $37 billion rout
A combination of increasing doubts about interest rate cuts, worries about AI overvaluation and a share crunch on Wall Street combined to strip four months of growth off the Australian share market.

Good News and Bad News About Aussie Superannuation
When it comes to Australia’s $4.3 trillion superannuation system, there are some things going particularly well, and others not so well.

How to Snag an ASX Bargain
One of the best ways to score a bargain when shopping is to trawl through the bargain bins and sales items to find something of good quality selling much cheaper than normal. Take Australian Foundation Investment Company (ASX: AFI), for example.

Calix Signs $35m Development Agreement with Rio Tinto for Zesty Green Iron Demonstration Plant
Calix (ASX: CXL) has made a significant breakthrough in its plans to develop a local green iron industry, with the signing of a $35 million joint development agreement with Rio Tinto (ASX: RIO).

The Lithium Turnaround: Pilbara, Liontown, IGO, MinRes, and Global Lithium Resources to Watch
Australia’s lithium industry is entering an exciting period. Global demand for lithium is rising sharply, electrification is accelerating, and Australia’s hard-rock lithium producers are perfectly positioned to benefit. From rising export earnings to operational leverage and selective growth opportunities, the fundamentals are compelling. We’ve captured the full story in a detailed report, including: Why lithium […]

Boss Energy on Track to Meet 2026 Guidance after Record September Quarter
Boss Energy (ASX: BOE) is on target to match its 2026 guidance after booking a record-breaking September quarter. The company generated robust free cash flow with strong production from its Honeymoon uranium project in South Australia, and costs lower than the forecast annual guidance. Boss enters the new quarter with zero debt, $212.4 million in […]

Boss Energy’s Alta Mesa Uranium Project Unveils New Mineralisation Discoveries
Boss Energy’s (ASX: BOE) investment in the Alta Mesa uranium project in Texas continues to pay off, with news that project operator enCore Energy has identified new uranium mineralisation near existing wellfields. The Australian company acquired a 30% interest in Alta Mesa from enCore in early 2024 for approximately $92 million and the rapidly expanding project’s […]

Zuleika Gold and Catalyst Metals Settle Five-Year Dispute over Plutonic Gold Mine
Zuleika Gold (ASX: ZAG) is celebrating a major legal win after reaching a final settlement in relation to its long-running Plutonic gold mine litigation against Catalyst Metals (ASX: CYL).

Calix Signs $35m Development Agreement with Rio Tinto for Zesty Green Iron Demonstration Plant
Calix (ASX: CXL) has made a significant breakthrough in its plans to develop a local green iron industry, with the signing of a $35 million joint development agreement with Rio Tinto (ASX: RIO).

Red Mountain Mining Gains Final Approval to List on US Mid-Tier OTCQB Stock Exchange
Red Mountain Mining (ASX: RMX) has been approved to list on the US mid-tier OTCQB stock exchange and has already demonstrated strong pre-listing secondary market activity with robust initial trading volumes and investor engagement.

PTR Minerals Continues to Grow Muckanippie Titanium Discovery with New Assay Results
PTR Minerals (ASX: PTR) has significantly expanded its high-grade Muckanippie titanium discovery in South Australia, with assay results from ongoing drilling at the Duke and Nardoo saprolite targets confirming the presence of high-grade titanium.

Island Pharmaceuticals Employs FDA Animal Rule in Development of Galidesivir to Counter Deadly Marburg Virus
Island Pharmaceuticals (ASX: ILA) has been granted an opportunity to advance approval of its lead candidate Galidesivir under the US Food and Drug Administration’s Animal Rule.

Biotron Advances Hepatitis B Program with Strong Clinical Results Across Key HBV Markers
Biotron (ASX: BIT) has reported a major step forward in its Hepatitis B Virus drug development program, confirming robust antiviral activity for its lead compound BIT-HBV001 across two established mouse models and multiple in vitro assays.

Algorae Pharmaceuticals Launches Upgraded Version of AlgoraeOS Drug Discovery Platform
Algorae Pharmaceuticals (ASX: 1AI), in collaboration with the UNSW and CSIRO, has launched a major upgrade to its AlgoraeOS AI-driven platform for the discovery of drug combinations.

CLEO Diagnostics Expands US Addressable Market for Pre-Surgical Ovarian Cancer Test
CLEO Diagnostics (ASX: COV) has used an analysis of insurance data to significantly expand the total addressable market in the US for its new pre-surgical ovarian cancer detection test.
Anteotech Hits Key Performance Benchmarks in Testing of Ultranode X High-Silicon Battery
AnteoTech (ASX: ADO) has reported that testing of its proprietary Ultranode X high-silicon anode has achieved more than 1,000 charge-discharge cycles at 80% capacity retention.

Iondrive Delivers Positive Economics for Modular Rare Earth Recycling As Phase 2 Validation Begins
Iondrive (ASX: ION) has completed a Phase 1 evaluation for a 2,000-tonne-per-annum modular plant designed to recover rare earth elements from end-of-life permanent magnets, with results indicating strong commercial potential for its IONSolv process.

Iondrive Poised to Disrupt Battery Recycling and Urban Mining with Breakthrough DES Technology
Iondrive Limited (ASX: ION) is emerging as a serious contender in the global race to secure critical minerals and rare earth elements for the clean energy transition.

Control Bionics Integrates Apple Brain–Computer Interface to Enhance Accessibility and Independence
Control Bionics (ASX: CBL) has implemented Apple’s new Brain–Computer Interface protocol across its product range, a major step forward in assistive communication technology for people living with severe speech and physical impairments.

3D Energi Intersects Two Gas-Bearing Reservoirs at Essington-1 Offshore Well in Otway Basin
3D Energi (ASX: TDO) has confirmed gas-bearing intervals in both the Waarre A and Waarre C reservoirs at its Essington-1 exploration well in the offshore Otway Basin, with wireline logging and pressure data indicating the presence of moveable gas.

Blue Energy Well Placed for Growing Queensland Gas Opportunities after Successful September Quarter
A string of successes in recent months has positioned Blue Energy (ASX: BLU) to support Queensland's new Energy Road Map, targeting increased capacity of gas and electricity generation between now and 2040.

BPH Energy Taking Plenty of Momentum Across Key Investments into 2026
Diversified investment company BPH Energy (ASX: BPH) will take plenty of momentum into the new calendar year after its investee companies undertook a range of needle-moving activities during the September 2025 quarter.

Altech Moves Closer to Global Commercialisation of Sodium Nickel Chloride and CERENERGY Batteries
Altech Batteries (ASX: ATC) has reported a busy three-month period to the end of September, spearheaded by ongoing developments with its sodium nickel chloride batteries and flagship CERENERGY battery project in Germany. The company made moves towards early market entry in Europe, Australia, and the US when it signed a collaboration agreement with global energy solutions company AMPower, […]

Bioxyne Receives $1.7m Funding from Scottish Government Agency for UK Medicinal Cannabis Manufacturing Facility
Bioxyne (ASX: BXN) subsidiary Breathe Life Sciences UK has received approximately $1.7 million in funding from economic development agency South of Scotland Enterprise (SOSE) to establish its UK medicinal cannabis manufacturing and distribution facility.

Bio-Gene Secures OMRI Approval for Qcide Organic Listing under USDA National Organic Program
Bio-Gene Technology (ASX: BGT) has received approval from the Organic Materials Review Institute in the US to list its Qcide natural insecticide as a Botanical Pesticide under the USDA National Organic Program.

Stealth Group Acquires Hardware & Building Traders To Create New Retail Option
Stealth Group (ASX: SGI) will spend $22 million to acquire Australian privately-owned buying group Hardware & Building Traders to create a market-leading alternative in hardware and industrial distribution.

How to Snag an ASX Bargain
One of the best ways to score a bargain when shopping is to trawl through the bargain bins and sales items to find something of good quality selling much cheaper than normal. Take Australian Foundation Investment Company (ASX: AFI), for example.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.

Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]

Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]

ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]

Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]